000			01012 a2200289 4500
005			20250512001038.0
264		0	_c19860417
008			198604s 0 0 eng d
022			_a0021-793X
040			_aNLM _beng _cNLM
100	1		_aSpedding, M
245	0	0	_aActivators and inactivators of Ca++ channels: new perspectives. _h[electronic resource]
260			_bJournal de pharmacologie _c
300			_a319-43 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_a3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester
650	0	4	_aAnimals
650	0	4	_aBinding Sites
650	0	4	_aCalcium Channel Blockers _xmetabolism
650	0	4	_aIn Vitro Techniques
650	0	4	_aIon Channels _xdrug effects
650	0	4	_aKinetics
650	0	4	_aNifedipine _xanalogs & derivatives
650	0	4	_aStimulation, Chemical
650	0	4	_aSurface Properties
773	0		_tJournal de pharmacologie _gvol. 16 _gno. 4 _gp. 319-43
999			_c2425761 _d2425761